Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Gene Therapy Market Analysis Report and Forecast Upto 2019

The Gene Therapy Market Research Report provides Industry analysis and evaluation of the current & prospective Market Size, Share, Trend and Growths.
Anjali Agrawal | 11.04.2017
©
The new research report on Gene Therapy Market offered by DecisionDatabases.com provides Global Industry Analysis, Size, Share, Growth, Trends and Forecast Upto 2019.

Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases. It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections). In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development.

Download Free Sample Copy Of this Report : http://www.decisiondatabases.com/contact/download-sample-412

Gene therapy market is segmented by types, technology, applications, vectors and geography. On the basis of types the market is segmented into somatic gene therapy and germline gene therapy. On the basis of technology the market is further segmented by type of gene therapy, physical methods and chemical methods. On the basis of type of gene therapy the market is further segmented into ex vivo gene therapy and in vivo gene therapy. On the basis of physical methods the market is segmented into electroporation, microinjection, particle bombardment, ultrasound-mediated transfection, molecular vibration, laser irradiation, photochemical transfection. On the basis of chemical methods the market is further segmented into gene repair and replacement, gene editing by using short synthetic oligonucleotides, genome engineering by using TALENs, genome engineering by using CRISPR system, mRNA gene therapy, spliceosome mediated RNA trans-splicing. On the basis of application the market is segmented into oncology, infectious diseases, genetic disorders, cardiovascular disorders, diabetes mellitus, hypertension and neurological disorder.

The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology. However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.

Major player assessed in the report are :
- AnGes MG, Inc
- Ark Therapeutics
- Ceregene, Inc
- Cobra Biologics
- GenVec, Inc
- Genzyme Corporation
- Vical, Inc
- Oxford BioMedica
- BioSante Pharmaceuticals
- More

Geographically, this market has been segmented into regions such as North America, Europe, Asia Pacific and Rest of the World. The study details country-level aspects based on each segment and gives estimates in terms of market size.

View More About this Report : http://www.decisiondatabases.com/ip/412-gene-therapy-market-report

Major Table of Contents :

1. Introduction
2. Executive Summary
3. Market Overview
4. Gene Therapy Market, By Type
5. Gene Therapy Market, By Application
6. Gene Therapy Market, By Technology
7. Gene Therapy Market, By Type of Vectors
8. Geographic Analysis
9. Competitive Landscape
10. Company Profiles

Follow us on LinkedIn for our latest upcoming reports : https://www.linkedin.com/company/decisiondatabases-com

About DecisionDatabases.com

DecisionDatabases.com is one stop shop for your Market research requirements like market reports, company profiles and industry databases. Our team consists of expert Business Analysts who have been trained to map your research requirement to the correct research resource.

Contact:
DecisionDatabases.com
Phone:
+91 99 28 237112
Email: sales@decisiondatabases.com
Web: www.decisiondatabases.com